Define the clinical finding
Diagnosis and a limited clinical aim precede device choice.
Device-Based Treatments · Physician-Led Assessment · Istanbul
Energy · Depth · Target tissue
Laser, light, radiofrequency and ultrasound are energy classes, not ready-made treatment protocols. The exact system, route, target tissue, labelled use and clinical aim must be identified before suitability is discussed.
Different devices sold under similar names are not assumed equivalent. No online page can choose settings, depth, applicator, treatment line or session number.
Physician-Led Orientation
Four levels before method selection
Online review can organise the question. Final suitability follows from in-person examination, the exact product or device and an individual risk–benefit assessment.
Diagnosis and a limited clinical aim precede device choice.
The exact device, energy source, applicator and consumables are verified.
Invasiveness, target depth, skin type and vulnerable anatomy shape suitability.
Device-specific evidence, alternatives, follow-up and stopping criteria are agreed.
Device-Based Treatments · 01–03
Needle, laser and ultrasound routes remain distinct
RF microneedling, fractional lasers and focused ultrasound differ in energy, route, target tissue and labelled context.
RF microneedling explained by needle system, radiofrequency delivery, device label, target tissue, evidence, risks, alternatives and stopping criteria.
Fractional laser treatment with ablative and non-ablative systems separated by wavelength, chromophore, tissue effect, recovery and safety.
Microfocused ultrasound and HIFU separated by device, imaging, transducer, focal depth, labelled use, tissue target, evidence and neurological risks.
Device-Based Treatments · 04–06
Light targets require diagnosis and chromophore logic
Broad-spectrum filtered light and wavelength-specific lasers retain separate target, skin-type and eye-safety decisions.
IPL explained as filtered broad-spectrum non-laser light with device, filter, pulse, chromophore, skin type, evidence and ocular safety boundaries.
Pigment laser treatment with diagnosis and malignancy exclusion before wavelength, pigment depth, skin type, evidence, risks and alternatives.
Vascular laser assessment by vessel diagnosis, diameter, depth, anatomy, wavelength, cooling, evidence, risks and alternatives.
Device-Based Treatments · 07–09
Current path, fibre path and low-level light stay separate
A shared marketing promise cannot merge unlike energy delivery, tissue exposure or evidence.
Radiofrequency skin tightening separated by electrode arrangement, energy path, invasiveness, tissue target, thermal control, evidence and implant risks.
Interstitial fibre laser separated from surface laser and surgery by fibre path, invasiveness, target tissue, licence, evidence, complications and alternatives.
Existing canonical page for wavelength-, irradiance-, dose- and device-specific light assessment.
Quality and Safety Framework
Four binding principles
Advertising language and package logic are replaced by product traceability, anatomy, proportionate alternatives and documented review.
A device name never substitutes for examination.
Similar marketing names do not make systems interchangeable.
Energy path and vulnerable structures define the safety boundary.
Expected reactions, complications and the endpoint are assessed before another procedure.
Bağdat Caddesi · Istanbul
International patient pathway
The in-person appointment remains the decision point. Product records, early safety, return travel and local medical access are considered before treatment.
History and photographs prepare discussion without selecting a device.
Diagnosis, anatomy, exact system, label and alternatives are reviewed.
Device, consumable, region and observations remain recorded.
Stop criteria and local medical access are agreed before departure.
The Doctor Aslan Approach

Medical decision before machine selection
Doctor Aslan keeps system identity, energy path, anatomy, label, evidence and alternatives in the same decision.
Laser, IPL, RF, ultrasound and LED retain different mechanisms.
Manufacturer, model, applicator and intended use remain traceable.
A test area, documented parameters and the observed tissue response can limit avoidable overtreatment.
Withholding a device remains a valid medical decision.
Frequently Asked Questions
Short and clear
These answers provide general orientation and do not replace personal diagnosis or treatment planning.
Selection begins with the diagnosis, personal finding and aim. Only then are the exact device, applicator, protocol, risks and alternatives compared.
No. It can organise records and questions. Final diagnosis, suitability and planning are determined only after an in-person medical examination in Istanbul.
No. A responsible plan states the baseline, task, review point and criteria for continuing, changing or stopping.
The contact route, expected reactions, warning signs, local medical help and documented follow-up checks are agreed before treatment.
Next Step
Define the finding · identify the device · compare alternatives